PCOS and nutritional approaches: Differences between lean and obese phenotype
Open accessAbstract
Polycystic Ovary Syndrome (PCOS) is an endocrine/metabolic disorder with an ever-increasing prevalence. It has various clinical characteristics; the cardinals are androgen excess, oligo-anovulatory infertility, polycystic ovaries, insulin resistance (IR), and cardiometabolic alterations. These disturbances are a consequence of PCOS's complex etiology. PCOS is mainly related to women with obesity; however, there are many PCOS lean patients too. Even though they share some aspects in their metabolic profiles, each group has individual differences in body composition and other parameters. Thus, in order to achieve successful therapeutic strategies, they should be tailored to these details. The authors reviewed PubMed's updated and related publications about body composition and nutritional strategies for PCOS lean and obese patients. As previous reports have determined, dietary patterns are essential in PCOS treatment. Several diets have been studied to control and improve IR, infertility, and cardiometabolic dysfunctions in PCOS. This review will explain the specific features in metabolic characterization and body composition among these patients. Finally, the diverse nutritional strategies used in women with PCOS will be analyzed depending on their lean or obese phenotype.
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review compares metabolic/body-composition features and nutritional approaches in lean versus obese PCOS phenotypes. It concludes that treatment should be phenotype-tailored: weight loss of at least 5–10% for obese PCOS, weight maintenance plus nutrient adequacy for lean PCOS, with the Mediterranean diet proposed as a favorable anti-inflammatory pattern.
Key findings
- PCOS prevalence is estimated at 10–15% worldwide; obesity is reported in 25–70% of women with PCOS, but a significant proportion have normal BMI (≤25 kg/m²). Lean and obese PCOS share hyperandrogenemia, insulin resistance, oxidative stress, and chronic inflammation, and non-obese PCOS may carry metabolic risk similar to obese PCOS because of similar visceral adipose tissue (Satyaraddi et al.: 81 patients, 42 obese and 39 non-obese).
- Nutritional goals differ by phenotype: obese PCOS should target weight loss of at least 5–10%, while lean PCOS should maintain weight and ensure adequate vitamins/minerals. The Mediterranean diet is highlighted for anti-inflammatory effects and association with decreased body weight; other studied diets include low saturated fat weight-loss, low GI, KEMEPHY, and very low carbohydrate diets.
- In the reviewed dietary studies, Marsh et al. found low-GI versus healthy diet produced greater improvement in insulin sensitivity, lower fibrinogen, and improved menstrual regularity; Paoli et al. reported KEMEPHY in 14 PCOS women reduced BMI from 28.84 to 25.49 kg/m² with 9.43 kg weight loss; Le Donne et al. reported weight losses of 8.1, 8.5, and 9.8 kg for diet only, diet plus myo-inositol, and diet plus myo-inositol plus D-chiro-inositol, respectively.
- Vitamin D supplementation may improve reproductive function, glucose metabolism, and lipid profile in PCOS; 25(OH)D is described as an independent predictor of total fat mass, and a suggested intake of 600–800 IU/day depending on age and gender is mentioned. Inositol stereoisomers are used to improve insulin resistance and reduce CVD risk factors, and bariatric surgery in severe obesity improved androgen levels, menstrual cycles, insulin sensitivity, and blood pressure.
Methods
- Narrative review of updated and related PubMed publications about body composition and nutritional strategies for lean and obese patients with PCOS.
- The paper discusses Rotterdam 2003 diagnostic criteria, body-composition assessment methods (CT, MRI, DEXA), and includes a table of reviewed studies assessing different dietary compositions in PCOS.
- No systematic review, meta-analysis, or formal risk-of-bias methodology is stated.
Limitations
- The paper states there is still no consensus on the best nutritional treatment for PCOS, the exact dietary macro- and micronutrient combination needed is undetermined, and more robust evidence and randomized trials are needed, especially for vitamin D. It also notes a lack of evidence on lifestyle intervention effects on glucose tolerance, lipid profiles, and clinical reproductive outcomes such as quality of life and treatment satisfaction.
- Evident from the text: this is a narrative review rather than a systematic review, and several cited dietary studies are small or heterogeneous (e.g., n=14 in Paoli et al.; n=43 in Le Donne et al.), limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 118 cited sources checked · 0 supported · 0 flagged
- Findingnone given
An increase in the frequency of body weight control methods has been observed in obese women who have undergone bariatric surgery.
“Notably, an increase in the frequency of body weight control methods has been observed, so health personnel must evaluate this aspect in their follow-up visits.”
Quote in the paperNot a substantial claim - Findingnone given
Some of these diets achieved significant weight loss in obese PCOS patients.
“Some of them have reached a significant weight loss in those PCOS obese patients.”
Quote in the paperSubstantial claim - Premisecitation
Androgens promote visceral fat accumulation and IR by inhibiting lipolysis and promoting lipogenesis.
“In turn, androgens promote visceral fat accumulation and IR by inhibiting lipolysis and promoting lipogenesis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Rosenfield, 2016, The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited, Endocr Rev source
Not checked in the free run.
- Premisecitation
A primary alteration in β-cell function has been suggested as a weight-independent pathophysiological component in women with PCOS.
“A primary alteration in β-cell function has been suggested as a weight-independent pathophysiological component in women with PCOS [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Messer, 2012, Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin, Endocr Pract source
Not checked in the free run.
- Interpretationcitation
Excess body fat may be an essential determinant of IR in PCOS.
“This finding supports the hypothesis that excess body fat may be an essential determinant of IR in PCOS [35].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Tosi, 2015, Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Lean women with PCOS have shown decreased sensitivity to catecholamine-mediated lipolysis in subcutaneous adipose tissue, resulting in preservation of this tissue.
“Lean women with PCOS have shown decreased sensitivity to catecholamine-mediated lipolysis in subcutaneous adipose tissue (SAT), which results in the preservation of this tissue [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Leung, 2020, Clin Epigenet source
Not checked in the free run.
- Premisecitation
Vitamin D deficiency occurs commonly in obese PCOS patients.
“There is evidence implying that vitamin D deficiency occurs commonly in obese PCOS patients [48,49].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [48] Muscogiuri, 2012, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?, Clin Nutr source
Not checked in the free run.
- cites [49] Davis, 2019, Associations between vitamin D levels and polycystic ovary syndrome phenotypes, Minerva Endocrinol source
Not checked in the free run.
- Premisecitation
Most studies addressing excess body fat in PCOS relied on approximate total or core fat mass indices such as BMI, waist circumference, or waist-to-hip ratio.
“Most of the studies that addressed excess body fat in PCOS relied on approximate total or core fat mass indices, such as body mass index (BMI) and waist circumference or waist-to-hip ratio [29].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Lim, 2012, Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis, Hum Reprod Update source
Not checked in the free run.
- Premisecitation
Barber et al. reported that visceral fat assessed by MRI was correlated with IR (HOMA2) in a small group of overweight women with PCOS.
“For their part, Barber et al. reported that visceral fat, assessed by MRI, was correlated with IR (HOMA2) in a small group of overweight women with PCOS [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Barber, 2008, Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
Carmina et al. found an inverse correlation between adiposity assessed by DEXA and insulin sensitivity (QUICKI) in patients with PCOS.
“In this sense, Carmina et al., found an inverse correlation between adiposity assessed by DEXA (total or central fat) and insulin sensitivity (QUICKI) in patients with PCOS [32].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Carmina, 2007, Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance, J Clin Endocrinol Metab source
Not checked in the free run.
- Interpretationreasoning
Hyperleptinemia found in normal-weight women with PCOS may be partially explained by leptin secretion primarily from subcutaneous adipose tissue.
“Because leptin is secreted primarily from SAT, this may partially explain the hyperleptinemia found in normal-weight women with PCOS”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Yildizhan, 2011, Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome, Fertil Steril source
Not checked in the free run.
- Premisecitation
PCOS involves two-way relationships between androgen excess, adipose dysfunction, IR, inflammation, and oxidative stress.
“However, this process has several vicious circles, with two-way relationships between androgen excess, adipose dysfunction, IR, and other actors, such as inflammation [24], and oxidative stress [25,26]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [24] Rostamtabar, 2020, Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome, J Cell Physiol
Not checked in the free run.
- cites [25] Zuo, 2016, Roles of oxidative stress in polycystic ovary syndrome and cancers, Oxid Med Cell Longev source
Not checked in the free run.
- cites [26] Khashchenko, 2020, Activation of systemic inflammation and oxidative stress in adolescent girls with polycystic ovary syndrome in combination with metabolic disorders and excessive body weight, J Clin Med source
Not checked in the free run.
- Premisecitation
Penaforte et al. reported that women with insulin-resistant PCOS, defined by QUICKI, had higher amounts of visceral and trunk abdominal fat, as measured by CT, than non-insulin-resistant women.
“Consistent with these findings, Penaforte et al. reported that women with insulin-resistant PCOS, as defined by QUICKI, had higher amounts of visceral and trunk abdominal fat, as measured by CT, than non-insulin-resistant women [34].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Penaforte, 2011, Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome, J Hum Nutr Diet source
Not checked in the free run.
- Premisecitation
After controlling for BMI-related effects, adiponectin levels appear to be lower in women with PCOS than in controls without PCOS.
“after controlling for BMI-related effects, adiponectin levels appear to be lower in women with PCOS than in controls without PCOS [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Toulis, 2009, Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis, Hum Reprod Update source
Not checked in the free run.
- Premisecitation
Non-obese PCOS has a similar risk to obese PCOS by having a similar amount of visceral adipose tissue corrected for body weight.
“Non-obese PCOS has a similar risk to obese PCOS by having a similar amount of visceral adipose tissue (corrected for body weight) [12].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Satyaraddi, 2019, Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome, J Hum Reprod Sci source
Not checked in the free run.
- Premisecitation
Obesity significantly impacts the PCOS phenotype because it is associated with a higher prevalence of menstrual irregularity, hyperandrogenemia, and hirsutism.
“Additionally, obesity significantly impacts the PCOS phenotype since it is associated with a higher prevalence of menstrual irregularity, hyperandrogenemia, and hirsutism [23].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Rosenfield, 2016, The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited, Endocr Rev source
Not checked in the free run.
- Premisecitation
Tosi et al. demonstrated that total or trunk fat mass is strongly and inversely associated with insulin-induced glucose clearance during clamping in a large cohort of women with PCOS.
“In a large cohort of women with PCOS, Tosi et al. demonstrated that total or trunk fat mass is strongly and inversely associated with insulin-induced glucose clearance during clamping, considered the gold standard for evaluating IR [35].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Tosi, 2015, Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
CT, MRI, and DEXA allow assessment of individual differences in body composition, fat distribution, and adipose tissue function.
“These tools allow the assessment of individual differences in body composition, fat distribution, and adipose tissue function [31].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Prado, 2014, Lean tissue imaging: a new era for nutritional assessment and intervention, JPEN - J Parenter Enter Nutr source
Not checked in the free run.
- Premisecitation
Visceral adiposity in PCOS is associated with increased IR, leading to exacerbation of reproductive and metabolic abnormalities.
“Visceral adiposity in PCOS is associated with increased IR, leading to exacerbation of reproductive and metabolic abnormalities [23].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Rosenfield, 2016, The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited, Endocr Rev source
Not checked in the free run.
- Premisecitation
PCOS can be a consequence of a lipid-induced proinflammatory state.
“since PCOS can be the consequence of a lipid-induced proinflammatory state”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] González, 2020, Inflammation triggered by saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
BMI is not an accurate descriptor of body composition and is surpassed by more specific techniques such as CT, MRI, and DEXA.
“It is important to note that BMI is not an accurate descriptor of body composition and is widely surpassed by more specific techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and dual-energy X-ray Absorptiometry (DEXA) [31].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Prado, 2014, Lean tissue imaging: a new era for nutritional assessment and intervention, JPEN - J Parenter Enter Nutr source
Not checked in the free run.
- Premisecitation
Weight gain and central obesity, although not a diagnostic criterion, are common features of PCOS.
“Weight gain and central obesity, although not a diagnostic criterion, are common features of PCOS [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Escobar-Morreale, 2007, Abdominal adiposity and the polycystic ovary syndrome, Trends Endocrinol Metabol source
Not checked in the free run.
- Interpretationreasoning
A better macronutrient distribution of the diet, despite not being intended for weight loss, may improve the constant inflammatory state.
“A better macronutrient distribution of the diet despite not being intended for weight loss may improve the constant inflammatory state.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] González, 2020, Inflammation triggered by saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
- Premisecitation
PCOS has been associated with an increased frequency of weight management methods.
“PCOS has been associated with an increased frequency of weight management methods [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Moran, 2017, Weight management practices associated with PCOS and their relationships with diet and physical activity, Hum Reprod
Not checked in the free run.
- Premisecitation
Studies converging weight-loss strategies and the use of inositol have shown that they could bring weight loss in subjects with PCOS.
“Also, studies that converge weight-loss strategies and the use of inositol have shown that they could bring weight loss in subjects with PCOS [66].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Le Donne, 2019, Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome, Eur Rev Med Pharmacol Sci
Not checked in the free run.
- Premisecitation
Obese phenotypes have more severe clinical forms of PCOS than their lean equivalent.
“In general, obese phenotypes have more severe clinical forms of PCOS than their lean equivalent.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Ganie, 2019, Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India, Indian J Med Res source
Not checked in the free run.
- Premisecitation
Vitamin D supplementation may improve reproductive function in women with PCOS by restoring regular menstrual cycles.
“For example, vitamin D supplementation may improve reproductive function in women with PCOS by restoring regular menstrual cycles [61,62].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [61] Muscogiuri, 2014, Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease, Eur J Endocrinol source
Not checked in the free run.
- cites [62] Menichini, 2020, Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review, Gynecol Endocrinol source
Not checked in the free run.
- Premisecitation
Lifestyle modifications such as dietary interventions and regular physical activity have demonstrated improved IR and ameliorated hyperandrogenism among other beneficial effects on PCOS symptoms.
“Many lifestyle modifications such as dietary interventions and regular physical activity have demonstrated improved IR and ameliorated hyperandrogenism amongst other beneficial effects on PCOS symptoms [57].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Orio, 2013, Effects of physical exercise on the female reproductive system, Minerva Endocrinol
Not checked in the free run.
- Premisecitation
Lean PCOS patients have increased plasma insulin 2 h after glucose administration compared with lean healthy participants.
“Several reports showed the different metabolic disturbances characteristics in PCOS patients, like increased plasma insulin levels 2 h after glucose administration to lean PCOS patients, correlated with the lean, healthy participants.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Orio, 2016, Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol source
Not checked in the free run.
- cites [30] Toosy, 2018, Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach, J Diabetes Metab Disord source
Not checked in the free run.
- cites [55] Han, 2015, Metabolic effects of polycystic ovary syndrome in adolescents, Ann Pediatr Endocrinol Metab source
Not checked in the free run.
- Premisecitation
IR, high androgen levels, and dyslipidemia have been found even in non-obese members of PCOS patients' families.
“IR, high androgen levels, and dyslipidemia have been found even in non-obese members of patients' families [36].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Vryonidou, 2015, Mechanisms IN endocrinology: metabolic syndrome through the female life cycle, Eur J Endocrinol source
Not checked in the free run.
- Premisecitation
Lean PCOS women have increased LDL and total cholesterol compared with controls.
“Also, important risen low-density lipoprotein (LDL) and total cholesterol have been associated in lean PCOS women versus controls [1,30,55].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [1] Orio, 2016, Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol source
Not checked in the free run.
- cites [30] Toosy, 2018, Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach, J Diabetes Metab Disord source
Not checked in the free run.
- cites [55] Han, 2015, Metabolic effects of polycystic ovary syndrome in adolescents, Ann Pediatr Endocrinol Metab source
Not checked in the free run.
- Premisecitation
The frequency of obese women with PCOS is greater than that of the general female population compared with their lean counterparts.
“The frequency of obese women with PCOS is greater than that of the general female population compared to their lean counterparts [1].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Orio, 2016, Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol source
Not checked in the free run.
- Premisenone given
The majority of PCOS patients have increased serum insulin and IR despite androgen and adiposity levels.
“Despite androgen and adiposity levels, the majority of PCOS patients have increased serum insulin and IR.”
Quote in the paperSubstantial claim - Premisecitation
There is solid evidence that genetic factors are part of PCOS etiology since there is a high prevalence of the syndrome in members of the same family.
“there is solid evidence that genetic factors are part of PCOS's etiology since there is a high prevalence of this syndrome in members of the same family.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Vryonidou, 2015, Mechanisms IN endocrinology: metabolic syndrome through the female life cycle, Eur J Endocrinol source
Not checked in the free run.
- Premisecitation
Vitamin D may be involved in several features of PCOS such as infertility, hirsutism, IR, and CVD risk.
“There is promising evidence from several studies suggesting that vitamin D may be involved in several features of PCOS, such as infertility [59], hirsutism, IR [60], and CVD risk.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [59] Muscogiuri, 2017, Shedding new light on female fertility: the role of vitamin D, Rev Endocr Metab Disord source
Not checked in the free run.
- cites [60] Sahin, 2014, Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome, Eur Rev Med Pharmacol Sci
Not checked in the free run.
- Premisereasoning
Obesity worsens the clinical severity of ovarian hyperandrogenism by increasing IR.
“Obesity worsens the clinical severity of OH by increasing IR.”
Quote in the paperSubstantial claim - Premisenone given
PCOS is associated with low-grade inflammation.
“PCOS is also associated with low-grade inflammation.”
Quote in the paperSubstantial claim - Interpretationcitation
The therapeutic role of foods and nutrients such as the Mediterranean dietary pattern in PCOS pathogenesis likely involves inflammatory status, IR, and hyperandrogenemia.
“This relation could support and demonstrate the therapeutic role of foods and nutrients such as the Mediterranean dietary pattern in the PCOS pathogenesis that likely involving their inflammatory status, IR, and hyperandrogenemia [8].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Barrea, 2019, Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS), Nutrients source
Not checked in the free run.
- Premisecitation
PCOS is usually more commonly found in obese women.
“PCOS is usually more commonly found in obese women [36].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Vryonidou, 2015, Mechanisms IN endocrinology: metabolic syndrome through the female life cycle, Eur J Endocrinol source
Not checked in the free run.
- Interpretationreasoning
The propensity for obesity appears to be secondary to underlying ovarian hyperandrogenism and hyperinsulinism.
“The propensity for obesity appears to be secondary to the underlying OH and hyperinsulinism.”
Quote in the paperSubstantial claim - Interpretationreasoning
Chronic inflammation mediates long-term cardiometabolic complications and comorbidities in PCOS including dyslipidemia, metabolic syndrome, T2D, and cardiovascular disease.
“These situations lead to chronic inflammation that mediates long-term cardiometabolic complications and comorbidities seen in women with POCS, including dyslipidemia, metabolic syndrome, T2D, and cardiovascular disease.”
Quote in the paperNot a substantial claim - Premisecitation
Both obese and lean PCOS share many central pathophysiological processes including hyperandrogenemia, IR, oxidative stress, and chronic inflammation.
“However, both share many central pathophysiological processes (hyperandrogenemia, IR, oxidative stress, chronic inflammation) [4].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Ganie, 2019, Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India, Indian J Med Res source
Not checked in the free run.
- Premisecitation
There is a lack of evidence regarding the effect of lifestyle intervention on improving glucose tolerance or lipid profiles and assessing clinical reproductive outcomes such as quality of life and treatment satisfaction.
“However, there is a lack of evidence regarding the effect of this lifestyle intervention on improving glucose tolerance or lipid profiles and assessing clinical reproductive outcomes, such as quality of life and treatment satisfaction [63].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Goyal, 2017, Debates regarding lean patients with polycystic ovary syndrome: a narrative review, J Hum Reprod Sci source
Not checked in the free run.
- Premisecitation
Oxidative stress and low-grade inflammation are shared equally by obese and non-obese patients with PCOS.
“Finally, oxidative stress and low-grade inflammation are two characteristics shared equally by obese and non-obese patients with PCOS [54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Frias-Toral, 2021, Polycystic ovary syndrome and obesity: clinical aspects and nutritional management, Minerva Endocrinol (Torino)
Not checked in the free run.
- Premisecitation
Lean PCOS patients may or may not have cardinal symptoms such as irregular menstrual cycles and acne.
“These lean PCOS patients may or may not have the cardinal symptoms such as irregular menstrual cycles and acne [30].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Toosy, 2018, Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach, J Diabetes Metab Disord source
Not checked in the free run.
- Interpretationcitation
Women with PCOS may be more likely to perceive themselves at risk of excessive weight gain.
“These findings may be related to women with PCOS being more likely to perceive themselves at risk of excessive weight gain [[67], [68], [69]].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [67] Moran, 2017, Weight management practices associated with PCOS and their relationships with diet and physical activity, Hum Reprod
Not checked in the free run.
- cites [68] Muscogiuri, 2021, Nutritional guidelines for the management of insulin resistance, Crit Rev Food Sci Nutr
Not checked in the free run.
- cites [69] Barrea, 2018, Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome, Nutr Res Rev source
Not checked in the free run.
- Premisecitation
The Mediterranean diet may decrease many risk factors for metabolic disorders such as endothelial dysfunction, fatty acid alterations, and IR due to its characteristics.
“Among the different nutritional strategies, the MD is recognized as a dietary pattern due to its characteristics, like consumption of fatty acids, omega-3 unsaturated fatty acids, and diminished consumption of animal-derived proteins that may decrease many risk factors for metabolic disorders such as endothelial dysfunction, fatty acids alterations and IR [56,67].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [56] Barrea, 2019, Association between Mediterranean diet and hand grip strength in older adult women, Clin Nutr source
Not checked in the free run.
- cites [67] Moran, 2017, Weight management practices associated with PCOS and their relationships with diet and physical activity, Hum Reprod
Not checked in the free run.
- Premisecitation
Physical activity improves infertility in women.
“Physical activity has shown improvement in infertility in women.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [71] Palomba, 2014, Physical activity before IVF and ICSI cycles in infertile obese women: an observational cohort study, Reprod Biomed Online source
Not checked in the free run.
- cites [72] Broughton, 2017, Obesity and female infertility: potential mediators of obesity's impact, Fertil Steril source
Not checked in the free run.
- Premisenone given
Various diets (low saturated fat weight-loss diet, low GI diet, KEMEPHY diet with phytoextracts, very low carbohydrate diet) have positively improved some aspects of PCOS characteristics.
“Various diets have been studied to treat PCOS, such as the low saturated fat weight-loss diet, low GI diet, the KEMEPHY diet with phytoextracts, and a very low carbohydrate diet. All of them have positively improved some aspects of the PCOS characteristics.”
Quote in the paperSubstantial claim - Premisecitation
In women with severe obesity and PCOS, weight loss via gastric surgery improves testosterone, hirsutism, and menstrual dysfunction.
“In 2017 a study concluded that weight loss in women with severe obesity and PCOS with gastric surgery resulted in improvement of male hormones like testosterone, hirsutism, and menstrual dysfunction [17].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Paoli, 2020, Effects of a ketogenic diet in overweight women with polycystic ovary syndrome, J Transl Med source
Not checked in the free run.
- Interpretationnone given
A significant proportion of women with PCOS have normal BMI despite the high prevalence of obesity in PCOS.
“Even though of the high prevalence of PCOS women with obesity, it is not unusual to find a significant proportion of patients with normal BMI.”
Quote in the paperSubstantial claim - Interpretationcitation
In obese PCOS, weight loss restores regular 25(OH)D levels and insulin sensitivity as a result of total fat mass loss.
“Therefore, weight loss should be kept in mind in the management of obese PCOS to restore regular 25(OH)D levels, insulin-sensitivity as a result of total fat mass loss [14,48].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [14] Faghfoori, 2017, Nutritional management in women with polycystic ovary syndrome: a review study, Diabetes Metab Syndr source
Not checked in the free run.
- cites [48] Muscogiuri, 2012, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?, Clin Nutr source
Not checked in the free run.
- Rests on an assumption: 25(OH)D levels are an independent predictor of total fat mass in PCOS patients.
- Rests on an assumption: Vitamin D plays a role in various metabolic pathways, including glucose metabolism.
- Premisecitation
In a retrospective cohort study of obese infertile women undergoing IVF, regular physical activity was associated with significantly higher pregnancy rates compared with inactivity.
“In a retrospective cohort study of obese infertile women undergoing cycles of in-vitro fertilization, the results of patients with regular physical activity were compared with those who were inactive. There were significantly more elevated pregnancy rates in the first group [71,72].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [71] Palomba, 2014, Physical activity before IVF and ICSI cycles in infertile obese women: an observational cohort study, Reprod Biomed Online source
Not checked in the free run.
- cites [72] Broughton, 2017, Obesity and female infertility: potential mediators of obesity's impact, Fertil Steril source
Not checked in the free run.
- Interpretationnone given
Physical activity has a fundamental role in strategies to improve lifestyle for PCOS treatment.
“Within the strategies to improve the lifestyle for PCOS treatment, physical activity has a fundamental role. It has been demonstrated that it improves several factors related to PCOS.”
Quote in the paperSubstantial claim - Premisecitation
Vitamin D supplementation improves reproductive function in women with PCOS.
“Also, vitamin D supplementation has been reported to improve reproductive function in women with PCOS.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [48] Muscogiuri, 2012, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?, Clin Nutr source
Not checked in the free run.
- cites [61] Muscogiuri, 2014, Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease, Eur J Endocrinol source
Not checked in the free run.
- cites [74] Muscogiuri, 2017, Vitamin D and chronic diseases: the current state of the art, Arch Toxicol source
Not checked in the free run.
- cites [75] Karamali, 2017, Effects of calcium, vitamins D and K co-supplementation on markers of insulin metabolism and lipid profiles in vitamin D-deficient women with polycystic ovary syndrome, Exp Clin Endocrinol Diabetes source
Not checked in the free run.
- Premisecitation
Obesity significantly impacts the pathophysiology of obesity-related infertility.
“A study of women with PCOS who underwent laparoscopic bypass, lowering androgen levels and menstrual cycles, insulin sensitivity, and blood pressure demonstrated that obesity significantly impacts the pathophysiology of obesity-related infertility [72].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] Broughton, 2017, Obesity and female infertility: potential mediators of obesity's impact, Fertil Steril source
Not checked in the free run.
- Interpretationnone given
Women with PCOS and normal BMI have elevated serum insulin and insulin resistance regardless of androgen concentrations and adiposity levels.
“Regardless of androgen concentrations and adiposity levels, these women have elevated serum insulin and IR.”
Quote in the paperNot a substantial claim - Premisecitation
The main impact of the Mediterranean diet on inflammatory activity is due to microbiota modulation as a result of dietary fiber and high intake of PUFA omega 3 and antioxidants.
“The main impact on inflammatory activity is due to the microbiota modulation as a result of the dietary fiber and the high intake of both polyunsaturated fatty acids (PUFA) omega 3 and antioxidants [56].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Barrea, 2019, Association between Mediterranean diet and hand grip strength in older adult women, Clin Nutr source
Not checked in the free run.
- Premisecitation
25(OH)D may be involved in complications related to PCOS, such as fertility, hirsutism, glucose metabolism, and CVD risk.
“several studies have suggested that 25(OH)D may be involved in complications related to PCOS, such as fertility, hirsutism, glucose metabolism, and CVD risk [48,61]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [48] Muscogiuri, 2012, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?, Clin Nutr source
Not checked in the free run.
- cites [61] Muscogiuri, 2014, Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease, Eur J Endocrinol source
Not checked in the free run.
- May combine two claims. 40
- Classified as probably not a substantial claim. 21
- The quote only partly states this claim. 1
May combine two claims.
Findingnone givenIn obese women who have undergone bariatric surgery, improvements in androgen levels, menstrual cycles, insulin sensitivity, and blood pressure have been found.
“In obese women who have undergone bariatric surgery, an improvement has been found by reducing androgen levels and menstrual cycles, insulin sensitivity, and blood pressure.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationVitamin D signaling through the vitamin D receptor improves insulin receptor mRNA genomic input, initiating insulin synthesis and discharge and restraining pro-inflammatory cytokines related to IR pathogenesis.
“The insulin receptor mRNA genomic input is improved by Vitamin D signaling through vitamin D receptor (VDR) [47]. This action initiates insulin synthesis and discharge. It also restrains some pro-inflammatory cytokines directly related to the IR pathogenesis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Barrea, 2021, Vitamin D in obesity and obesity-related diseases: an overview, Minerva Endocrinol (Torino)
Not checked in the free run.
May combine two claims.
PremisecitationObese and lean women with PCOS, compared with controls, are metabolically worse and have more visceral adiposity.
“A study by Satyaraddi et al. shows that obese and lean women with PCOS, compared to the control group, are metabolically worse and have more visceral adiposity”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Satyaraddi, 2019, Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome, J Hum Reprod Sci source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationNon-obese PCOS presents a metabolic risk similar to that of obese PCOS because they have a similar amount of visceral adipose tissue.
“concluding that non-obese PCOS presents a metabolic risk similar to that of obese patients because they present a similar amount of visceral adipose tissue [12].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Satyaraddi, 2019, Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome, J Hum Reprod Sci source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationSatyaraddi et al. in a case-control study with 81 patients with PCOS (42 obese and 39 non-obese) using DEXA concluded that both obese and non-obese women with PCOS, compared to age controls with the same BMI, were metabolically worse and had more visceral adiposity.
“Satyaraddi et al. in a case-control study with 81 patients with PCOS (42 obese and 39 non-obese), evaluated the disposition of fat using DEXA and concluded that both obese and non-obese women”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Satyaraddi, 2019, Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome, J Hum Reprod Sci source
Not checked in the free run.
May combine two claims.
PremisecitationLow saturated fat weight-loss diet, low GI diet, KEMEPHY diet, and very low carbohydrate diet have been studied in PCOS.
“Other diets that have been studied are the low saturated fat weight-loss diet, low GI diet [16], the ketogenic Mediterranean with phytoextracts (KEMEPHY) diet [17], and the very low carbohydrate diet.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [16] Marsh, 2010, Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome, Am J Clin Nutr source
Not checked in the free run.
- cites [17] Paoli, 2020, Effects of a ketogenic diet in overweight women with polycystic ovary syndrome, J Transl Med source
Not checked in the free run.
May combine two claims.
PremisecitationPCOS occurs in lean women as well as in obese women.
“It is important to note that PCOS is not exclusive to obese women; it also occurs in lean women.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Satyaraddi, 2019, Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome, J Hum Reprod Sci source
Not checked in the free run.
May combine two claims.
PremisecitationInsulin hypersecretion is the probable underlying mechanism in PCOS and is present in both lean and obese subjects.
“Insulin hypersecretion is the probable underlying mechanism in this scenario, present in both lean and obese subjects [42].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Vrbíková, 2002, Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome, Diabetes Care source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFaghfoori et al. recommend a dietary treatment that impacts IR control and metabolic functions through a hypocaloric diet, low simple sugars and refined carbohydrates, and promotion of low glycemic index foods.
“according to Faghfoori et al., it is recommended to carry out a dietary treatment that has an impact on the control of IR, metabolic functions from a hypocaloric diet, with a low contribution of simple sugars and refined carbohydrates, promoting the intake of foods with a low glycemic index (GI) [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Faghfoori, 2017, Nutritional management in women with polycystic ovary syndrome: a review study, Diabetes Metab Syndr source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAdiponectin expression is down-regulated by obesity.
“It has been proposed that adiponectin expression is down-regulated by obesity [43].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Stefan, 2002, Adiponectin--its role in metabolism and beyond, Horm Metab Res source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationReduction of saturated and trans fatty acid intake is sought, and attention should be paid to possible deficiencies such as vitamin D, chromium, and omega-3.
“Likewise, the reduction of the contribution of saturated and trans fatty acids will be sought, and attention should be paid to possible deficiencies such as vitamin D, chromium, and omega-3 [14].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Faghfoori, 2017, Nutritional management in women with polycystic ovary syndrome: a review study, Diabetes Metab Syndr source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe Mediterranean diet can be an adequate dietary treatment for PCOS due to its anti-inflammatory effect and its relationship with decrease in body weight.
“it has been postulated that the Mediterranean diet (MD) can be an adequate dietary treatment for PCOS due to its anti-inflammatory effect and its relationship with the decrease in body weight [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Barrea, 2019, Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS), Nutrients source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenEnvironmental factors such as eating habits play an essential role in preventing and treating women with PCOS.
“It seems clear that environmental factors such as eating habits play an essential role in preventing and treating women with PCOS.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe obese phenotype of PCOS differs from the lean phenotype based on BMI being above or below the normal limit for age and ethnicity.
“In practice and research studies, the obese phenotype of PCOS differs from lean based on BMI, that is, if it is above or below, respectively, the limit considered normal for age and ethnicity [30].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Toosy, 2018, Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach, J Diabetes Metab Disord source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
PremisecitationA healthy diet with adequate distribution of macronutrients seems to be a good option for PCOS.
“a healthy diet with adequate distribution of macronutrients seems to be a good option [15].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] González, 2020, Inflammation triggered by saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome, J Clin Endocrinol Metab source
Not checked in the free run.
May combine two claims.
PremisecitationNon-obese women with PCOS have lower insulin levels and IR associated with higher levels of sex hormone-binding globulin, but hyperinsulinemia remains a common finding.
“While non-obese women have lower insulin levels and IR [38] associated with higher levels of sex hormone-binding globulin [39], hyperinsulinemia remains a common finding in this population [40].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [38] Unluer, 2013, Comparison of HbA1c levels in obese and non-obese polycystic ovarian patients, Clin Exp Obstet Gynecol
Not checked in the free run.
- cites [39] Silfen, 2003, Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents, J Clin Endocrinol Metab source
Not checked in the free run.
- cites [40] Dahan, 2019, Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome, Endocrine source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationInternational recommendations indicate that weight control is one of the main treatment strategies for PCOS because obesity worsens the clinical presentation of the syndrome.
“International recommendations indicate that weight control is one of the main treatment strategies for PCOS since obesity worsens the clinical presentation of this syndrome [13].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Hum Reprod source
Not checked in the free run.
May combine two claims.
InterpretationcitationLow adiponectin levels in PCOS are likely related to IR, but not to testosterone.
“Low adiponectin levels in PCOS are likely related to IR, but not testosterone [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Toulis, 2009, Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis, Hum Reprod Update source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMore elevated adhesion to the Mediterranean diet is related to larger Phase Angle as evidence of cell stability, a positive effect of MD on PCOS.
“Also, a more elevated adhesion to the MD related to larger Phase Angle has been published as evidence of cell stability, as another positive effect of MD on PCOS [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Barrea, 2017, Mediterranean diet and Phase Angle in a sample of adult population: results of a pilot study, Nutrients source
Not checked in the free run.
May combine two claims.
PremisecitationBeyond obesity, metabolic abnormalities in PCOS include dyslipidemias, IR, hyperinsulinemia, and glucose intolerance.
“Beyond obesity, the metabolic abnormalities found in PCOS include dyslipidemias, IR, hyperinsulinemia, and glucose intolerance [36].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Vryonidou, 2015, Mechanisms IN endocrinology: metabolic syndrome through the female life cycle, Eur J Endocrinol source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenThis type of inflammation and hyperandrogenism are linked to saturated fat.
“This type of inflammation and hyperandrogenism are linked to saturated fat.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenHyperinsulinemia affects the ovary selectively, which persists insulin sensitive, while liver and skeletal muscle evidence IR.
“Hyperinsulinemia affects the ovary selectively, which persists insulin sensitive, while liver and skeletal muscle evidence IR.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenAndrogens oppose the effects of insulin on subcutaneous fat stores, while hyperandrogenemia promotes the accumulation of visceral fat.
“Androgens oppose the effects of insulin on subcutaneous fat stores, while hyperandrogenemia promotes the accumulation of visceral fat.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationHigher adherence to the Mediterranean diet has been proven effective in preserving skeletal muscle mass in healthy women, likely due to anti-inflammatory and antioxidant properties of micronutrients or their direct role in muscle metabolism.
“Higher adherence to this nutritional approach has also been proven to be effective in preserving the skeletal muscle mass in healthy women, likely due to the potential anti-inflammatory and antioxidant properties of micronutrients or through their direct role in muscle metabolism and physiology, such as with magnesium and potassium [56].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Barrea, 2019, Association between Mediterranean diet and hand grip strength in older adult women, Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationObesity is reported in 25-70% of women with PCOS, but a significant proportion of patients have PCOS despite having a normal BMI (≤25 kg/m2).
“Obesity is reported in 25–70% of women with PCOS, but a significant proportion of patients have it despite having a normal BMI (≤25 kg/m2) [36].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Vryonidou, 2015, Mechanisms IN endocrinology: metabolic syndrome through the female life cycle, Eur J Endocrinol source
Not checked in the free run.
May combine two claims.
PremisecitationMarsh et al. 2010 found that a low-GI diet versus a healthy diet in PCOS produced greater improvement in insulin sensitivity, lower fibrinogen, and improved menstrual regularity, with no significant differences in other outcomes.
“Low-GI vs healthy diet: Greater improvement in insulin sensitivity, lower fibrinogen, improved menstrual regularity.No significant differences in other outcomes”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Marsh, 2010, Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome, Am J Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationLean PCOS women had more diminished HDL and HDL2 levels than women with normal ovarian function, while obese PCOS individuals also presented increased triglyceride levels.
“Lean PCOS women had more diminished HDL and HDL2 levels than their counterparts with normal ovarian function, while obese PCOS individuals also presented increased triglyceride levels [53].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Diamanti-Kandarakis, 2007, Pathophysiology and types of dyslipidemia in PCOS, Trends Endocrinol Metabol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
PremisereasoningVisceral fat gives more IR than subcutaneous abdominal fat due to its increased lipolytic response to catecholamines.
“Due to its increased lipolytic response to catecholamines, visceral fat gives more IR than subcutaneous abdominal fat.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMost studies report a decrease in HDL cholesterol and an increase in triglyceride levels in PCOS, the same lipid profile associated with IR.
“Most studies report a decrease in HDL cholesterol and an increase in triglyceride levels, the same lipid profile that is known to be associated with IR.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
InterpretationreasoningA lipid-stimulated proinflammatory status may cause the characteristic IR, hyperandrogenism, and dyslipidemia frequently found in PCOS women.
“A lipid-stimulated proinflammatory status may cause the characteristic IR, hyperandrogenism, and dyslipidemia frequently found in PCOS women.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenInflammation and IR are often associated with PCOS.
“As stated before, inflammation and IR are often associated with PCOS.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPaoli et al. 2020 found that the KEMEPHY diet in PCOS improved testosterone, DHEAs, LH, and FSH, with weight loss of 9.43 kg and BMI at the end of intervention of 25.49 kg/m2.
“Improvement in levels:Testosterone, DHEAs, LH, FSH.Weight loss: 9,43 kgBMI at the end of intervention: 25,49 kg/m2”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Paoli, 2020, Effects of a ketogenic diet in overweight women with polycystic ovary syndrome, J Transl Med source
Not checked in the free run.
May combine two claims.
PremisecitationExcessive weight has a significant impact on the PCOS phenotype because it is associated with a greater prevalence of menstrual and hormonal irregularity, and hirsutism.
“Also, excessive weight has a significant impact on the PCOS phenotype since it is associated with a greater prevalence of menstrual and hormonal irregularity, and hirsutism [1].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Orio, 2016, Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome, Eur J Obstet Gynecol Reprod Biol source
Not checked in the free run.
May combine two claims.
PremisecitationLe Donne et al. 2019 found that diet alone, diet plus MI, and diet plus inositols in PCOS produced weight loss of 8.1, 8.5, and 9.8 kg respectively and significant fat mass lost for group 1.
“Weight loss: 8.1, 8.5 and 9.8 kg for Group 1,2,3 respectively and significant fat mass lost for Group 1”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] Moran, 2013, Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines, J Acad Nutr Diet source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing). May combine two claims.
PremisecitationDecreased vitamin D levels and IR are independent body size characteristics in PCOS patients.
“Some publications state that decreased vitamin D levels and IR are independent body size characteristics in PCOS patients.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [48] Muscogiuri, 2012, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?, Clin Nutr source
Not checked in the free run.
- cites [49] Davis, 2019, Associations between vitamin D levels and polycystic ovary syndrome phenotypes, Minerva Endocrinol source
Not checked in the free run.
- cites [54] Frias-Toral, 2021, Polycystic ovary syndrome and obesity: clinical aspects and nutritional management, Minerva Endocrinol (Torino)
Not checked in the free run.
May combine two claims.
PremisecitationIn the general population, low-calorie diets with fat modifications, Mediterranean diet, ketogenic diet, and reduction in dietary GI in addition to overall calorie reduction to induce weight loss may have a positive effect on IR.
“In the general population, research evaluating the effects of varying dietary recommendations differs from low-calorie diets with fat modifications, MD, ketogenic diet (KD) and reduction in the dietary GI in addition to overall calorie reduction to induce weight loss may have a positive effect on IR (Table 1) [64,65].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [64] Moran, 2013, Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines, J Acad Nutr Diet source
Not checked in the free run.
- cites [65] Muscogiuri, 2016, Current insights into inositol isoforms, Mediterranean and ketogenic diets for polycystic ovary syndrome: from bench to bedside, Curr Pharmaceut Des source
Not checked in the free run.
May combine two claims.
PremisereasoningIn the ovary, hyperinsulinism cooperates with LH to up-regulate androgen generation, causing premature luteinization of granulosa cells and complicating hyperandrogenism.
“In the ovary, hyperinsulinism cooperates with LH to up-regulate androgen generation. These effects cause premature luteinization of granulosa cells complicating hyperandrogenism.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNutrition is a major modifiable environmental risk factor for several non-communicable diseases and plays an essential role in their prevention and initial treatment.
“Nutrition is one of the major modifiable environmental risk factors for several non-communicable diseases and plays an essential role in their prevention and initial treatment [56].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Barrea, 2019, Association between Mediterranean diet and hand grip strength in older adult women, Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationLifestyle intervention improves body composition, hyperandrogenism, and IR in women with PCOS.
“Lifestyle intervention has been helpful as it improves body composition, hyperandrogenism, and IR in women with PCOS.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Goyal, 2017, Debates regarding lean patients with polycystic ovary syndrome: a narrative review, J Hum Reprod Sci source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDyslipidemia is probably the most common metabolic disorder in PCOS, detected in 70% of patients according to NCEP guidelines.
“Dyslipidemia is probably the most common metabolic disorder in PCOS detected in 70% of patients according to the National Cholesterol Education Program (NCEP) guidelines [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Jacewicz-Święcka, 2020, Changes in metabolic profile in the women with a history of PCOS-A long-term follow-up study, J Clin Med source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe common denominator in PCOS seems to be ovarian hyperandrogenism, with IR and consequent hyperinsulinemia as a nonessential but common aggravating factor.
“The common denominator in PCOS seems to be OH, with IR and consequent counterbalancing hyperinsulinemia, a nonessential but common aggravating factor in this pathophysiology.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationExcessive adiposity in PCOS is associated with increased IR rates, resulting in aggravation of reproductive and metabolic abnormalities.
“Excessive adiposity in PCOS is associated with increased IR rates, resulting in reproductive and metabolic abnormalities aggravation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBariatric surgery changes PCOS complications such as ovulation rates, menstrual regularity, CVD, decreasing waist circumference, and total fat mass.
“Bariatric surgery does appear to change the PCOS complications such as ovulation rates, menstrual regularity, CVD, decreasing waist circumference, and total fat mass.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] Broughton, 2017, Obesity and female infertility: potential mediators of obesity's impact, Fertil Steril source
Not checked in the free run.
May combine two claims.
PremisecitationIn the last couple of years, the women population presented lower intake of energy-dense nutrient-poor foods and soda drinks, and higher intake of fruits and legumes, thus higher adherence to the Mediterranean diet that could support a therapeutic role of the dietary pattern on PCOS.
“In the last couple of years, there has been observed that women population presented lower intake of energy-dense nutrient-poor foods and soda drinks, and higher intake of fruits and legumes thus higher adherence to the MD that could support a therapeutic role that has the dietary pattern on PCOS [8,56].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [8] Barrea, 2019, Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS), Nutrients source
Not checked in the free run.
- cites [56] Barrea, 2019, Association between Mediterranean diet and hand grip strength in older adult women, Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationInositol stereoisomers (MYO-INS and DCI) are used for treatment of PCOS by improving insulin resistance and reducing CVD risk factors.
“The stereoisomers of inositol such as Myo-inositol (MYO-INS) and D-chiro-inositol (DCI) are currently being used for the treatment of PCOS by improving IR and reducing CVD risk factors [51,76]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [51] Muscogiuri, 2016, Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome, Endocrine source
Not checked in the free run.
- cites [76] Muscogiuri, 2016, Inositols in the treatment of insulin-mediated diseases, Int J Endocrinol
Not checked in the free run.
May combine two claims.
PremisecitationPhysical exercise decreases waist circumference, weight, and total fat mass in women with PCOS.
“decreasing waist circumference, weight, and total fat mass making exercise a positive non-pharmacological lifestyle change for PCOS [70]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] De Lima Nunes, 2019, Lifestyle interventions and quality of life for women with polycystic ovary syndrome: a systematic review and meta-analysis protocol, Medicine (Baltimore) source
Not checked in the free run.
May combine two claims.
PremisecitationWeight loss by 5-10% can improve insulin and testosterone levels and improve menstrual hormones.
“Weight loss, by 5–10%, can improve insulin and testosterone levels and improve menstrual hormones [64,68].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [64] Moran, 2013, Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines, J Acad Nutr Diet source
Not checked in the free run.
- cites [68] Muscogiuri, 2021, Nutritional guidelines for the management of insulin resistance, Crit Rev Food Sci Nutr
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenIR, dyslipidemia, and hyperandrogenism might result from a lipid-induced pro-inflammatory state.
“A healthy dietary pattern with satisfactory macronutrient distribution is essential in these patients since IR, dyslipidemia, and hyperandrogenism might result from a lipid-induced pro-inflammatory state.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationInternational guidelines for assessing and managing PCOS (2018) recommend variations in intensity and time of exercise as a lifestyle change to improve overall health in individuals with PCOS.
“International guidelines for assessing and managing PCOS (2018) indicate that variations on intensity and time of exercise are recommended as a lifestyle change to improve overall health in individuals with PCOS [73]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73] Pani, 2020, From prediabetes to type 2 diabetes mellitus in women with polycystic ovary syndrome: lifestyle and pharmacological management, Internet J Endocrinol
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningThe Mediterranean diet (MD) leads to better results in PCOS individuals because of its anti-inflammatory effect and its relationship with decreased body weight.
“However, the MD has been proposed as a possible eating guide that leads to better results in PCOS individuals because of its anti-inflammatory effect and its relationship with decreased body weight.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationVitamin D supplementation in women with PCOS improves reproductive function, glucose metabolism, and lipid profile.
“Intervention studies of vitamin D supplementation in women with PCOS have shown improvements in reproductive function, glucose metabolism, and lipid profile by improving reproductive function [48,61,74,75]”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [48] Muscogiuri, 2012, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?, Clin Nutr source
Not checked in the free run.
- cites [61] Muscogiuri, 2014, Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease, Eur J Endocrinol source
Not checked in the free run.
- cites [74] Muscogiuri, 2017, Vitamin D and chronic diseases: the current state of the art, Arch Toxicol source
Not checked in the free run.
- cites [75] Karamali, 2017, Effects of calcium, vitamins D and K co-supplementation on markers of insulin metabolism and lipid profiles in vitamin D-deficient women with polycystic ovary syndrome, Exp Clin Endocrinol Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationPhysical exercise improves ovulation rates, menstrual regularity, and cardiovascular disease (CVD) in women with PCOS.
“Physical exercise has been shown to improve several factors related to PCOS such as ovulation rates, menstrual regularity, CVD [9]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Orio, 2016, Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial, Clin Endocrinol (Oxf). source
Not checked in the free run.
May combine two claims.
PremisecitationIn women with PCOS who underwent laparoscopic bypass, androgen levels, menstrual cycles, insulin sensitivity, and blood pressure improved.
“A study of women with PCOS who underwent laparoscopic bypass, lowering androgen levels and menstrual cycles, insulin sensitivity, and blood pressure demonstrated that obesity significantly impacts the pathophysiology of obesity-related infertility [72].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] Broughton, 2017, Obesity and female infertility: potential mediators of obesity's impact, Fertil Steril source
Not checked in the free run.
The paper relies on this without support.
There is still no consensus on what is the best nutritional treatment for PCOS.
“There is still no consensus on what is the best nutritional treatment for PCOS.”
The paper relies on this without support.
The exact dietary macro- and micronutrient combination needed for a good nutritional plan to improve PCOS clinical characteristics is undetermined.
“Nevertheless, the exact dietary macro and micronutrient combination needed for a good nutritional plan to improve PCOS clinical characteristics are undetermined.”
The paper relies on this without support.
The specific dietary composition that should be implemented in obese PCOS remains controversial.
“The specific dietary composition that should be implemented remains quite controversial, which can be considered a challenge for clinicians.”
The paper relies on this without support.
25(OH)D levels are an independent predictor of total fat mass in PCOS patients.
“25(OH)D levels are an independent predictor of total fat mass in PCOS patients.”
The paper relies on this without support.
Vitamin D plays a role in various metabolic pathways, including glucose metabolism.
“Vitamin D plays a role in various metabolic pathways, including glucose metabolism.”
The paper relies on this without support.
Lack of 25(OH)D may cause inflammatory responses, thus worsening insulin resistance.
“the lack of 25(OH)D may cause inflammatory responses, thus worsening IR.”
The paper relies on this without support.
The indications for bariatric surgery are not different in women with PCOS (BMI ≥40 kg/m2 or ≥35 kg/m2 and severe morbidity presence).
“The indications for bariatric surgery are not different in women with PCOS (BMI ≥40 kg/m2 or ≥35 kg/m2 and severe morbidity presence.”
The paper relies on this without support.
The immunomodulatory role of vitamin D is well documented.
“the immunomodulatory role is well documented”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Most studies examining body composition in PCOS have relied on anthropomorphic measurements (BMI, waist circumference, waist-to-hip ratio) which are considered inaccurate compared with the current gold-standard of magnetic resonance imaging.
“In addition, most of the studies examining body composition in PCOS have relied on anthropomorphic measurements (BMI, waist circumference, waist-to-hip ratio) which are considered inaccurate compared with the current gold-standard of magnetic resonance imaging [182].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [182]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredStudies comparing obese and lean women with PCOS have several methodological problems including small sample size, overlap of PCOS characteristics with normal pubertal changes, non-standardized diagnostic criteria, and limited generalizability due to a focus on a specific ethnic group.
“Studies comparing obese and lean women with PCOS have several methodological problems including small sample size, overlap of PCOS characteristics with normal pubertal changes, non-standardized diagnostic criteria, and limited generalizability to the entire population due to a focus on a specific ethnic group [166,182].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [182]
The 'Nutritional approach to lean PCOS' section (page not provided) says that differences in diagnostic criteria across studies contribute to disparities in PCOS diagnosis. It does not identify overlap with normal pubertal changes, small sample sizes, or a focus on one ethnic group as general methodological problems in studies comparing lean and obese women. (LLM, conf=0.82)
Experimental — accuracy not yet measuredVisceral WAT is associated with insulin resistance in women with PCOS leading to both metabolic and reproductive problems.
“Visceral WAT is associated with IR in women with PCOS leading to both metabolic and reproductive problems [182].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [182]
PCOS also occurs in women who are not obese and risk is related to visceral fat mass.
“PCOS also occurs in women who are not obese and risk is related to visceral fat mass. 30 , 31”
From Overweight, obesity and excessive weight gain in pregnancy as risk factors for adverse pregnancy outcomes: A narrative review (2022) · cites this paper as [31]
Reducing weight in women with PCOS can improve insulin resistance, hypertension, dyslipidemia, type 2 diabetes, and other related morbidities.
“Reducing weight in women with PCOS can improve IR, hypertension, dyslipidemia, T2D, and other related morbidities, but ideal macronutrient distribution has not been standardized yet [1, 7, 11].”
From Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [1]
Lifestyle modifications such as dietary interventions, improved sleep patterns, and physical activity have ameliorated insulin resistance and hormone profiles in subjects with obesity.
“Lifestyle modifications such as dietary interventions, improved sleep patterns, and physical activity have ameliorated IR and hormone profiles in subjects with obesity [1, 46].”
From Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [1]
Obesity, insulin resistance, and compensatory hyperinsulinemia coexist with low-grade chronic inflammation within PCOS.
“The literature shows that obesity, IR, and compensatory hyperinsulinemia coexist low-grade chronic inflammation within this syndrome [1].”
From Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Le Donne study is assigned the wrong reference number
MinorTable 1 labels the Le Donne et al. 2019 study as reference [64], but reference [64] is a 2013 review by Moran et al. The Le Donne et al. 2019 study appears as reference [66].
“Le Donne et al., 2019 [64]”
“64. Moran L.J. Ko H. Misso M. Marsh K. Noakes M. Talbot M. Frearson M. Thondan M. Stepto N. Teede H.J. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines J Acad Nutr Diet 113 4 2013 Apr 520 545”
Bariatric-surgery statement cites a ketogenic-diet study
MinorThe text attributes a 2017 gastric-surgery finding to reference [17], but that reference is a 2020 study of a ketogenic diet, not gastric surgery.
“In 2017 a study concluded that weight loss in women with severe obesity and PCOS with gastric surgery resulted in improvement of male hormones like testosterone, hirsutism, and menstrual dysfunction [17].”
“17. Paoli A. Mancin L. Giacona M.C. Bianco A. Caprio M. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome J Transl Med 18 1 2020 Feb 27 104”
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138 · see citing works
Mediterranean diet pyramid: a cultural model for healthy eating
Willett, W., Sacks, F., Trichopoulou, A., Drescher, G., Ferro-Luzzi, A., Helsing, E., & Trichopoulos, D. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1402s · Cited by 2,461 · see citing works
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373 · see citing works
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083 · see citing works
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823 · see citing works
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603 · see citing works
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593 · see citing works
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939 · see citing works
Obesity and female infertility: potential mediators of obesity's impact
Broughton, D. E., & Moley, K. H. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.017 · Cited by 845 · see citing works
Lee, M., Wu, Y., & Fried, S. K. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.001 · Cited by 804 · see citing works
Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention
Prado, C. M. M., & Heymsfield, S. B. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114550189 · Cited by 550 · see citing works
Abdominal adiposity and the polycystic ovary syndrome
Escobar-Morreale, H. F., & Millán, J. L. S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.003 · Cited by 386 · see citing works
Roles of oxidative stress in polycystic ovary syndrome and cancers
Zuo, T., Zhu, M., & Xu, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8589318 · Cited by 319 · see citing works
Carmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., Di Fede, G., & Rini, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2725 · Cited by 317 · see citing works
Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A., & Savastano, S. (2019) · Nutrients · doi:10.3390/nu11102278 · Cited by 306 · see citing works
Self-citationPathophysiology and types of dyslipidemia in PCOS
Diamanti‐Kandarakis, E., Papavassiliou, A. G., Kandarakis, S., & Chrousos, G. P. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.07.004 · Cited by 301 · see citing works
Adiponectin - Its Role in Metabolism and Beyond
Stefan, N., & Stümvoll, M. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-34785 · Cited by 293 · see citing works
The pathogenesis and treatment of polycystic ovary syndrome: What’s new?
Bednarska, S., & Siejka, A. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/59380 · Cited by 284 · see citing works
Effects of a Ketogenic Diet in Overweight Women with Polycystic Ovary Syndrome
Paoli, A., Mancin, L., Giacona, M. C., Bianco, A., & Caprio, M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02277-0 · Cited by 281 · see citing works
Silfen, M. E., Denburg, M. R., Manibo, A. M., Lobo, R. A., Jaffe, R., Ferin, M., Levine, L. S., & Oberfield, S. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030617 · Cited by 269 · see citing works
Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndrome
Rostamtabar, M., Esmaeilzadeh, S., Tourani, M., Rahmani, A., Baee, M., Shirafkan, F., Saleki, K., Mirzababayi, S. S., Ebrahimpour, S., & Nouri, H. R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29912 · Cited by 268 · see citing works
Bisphenol A: an emerging threat to female fertility
Pivonello, C., Muscogiuri, G., Nardone, A., Garifalos, F., Provvisiero, D. P., Verde, N., de Angelis, C., Conforti, A., Piscopo, M., Auriemma, R. S., et al. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0558-8 · Cited by 263 · see citing works
Self-citationAdiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis
Toulis, K. A., Goulis, D. G., Farmakiotis, D., Georgopoulos, N. A., Katsikis, I., Tarlatzis, B. C., Papadimas, I., & Panidis, D. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp006 · Cited by 262 · see citing works
Moran, L. J., Ko, H., Misso, M., Marsh, K., Noakes, M., Talbot, M., Frearson, M., Thondan, M., Stepto, N., & Teede, H. J. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.11.018 · Cited by 259 · see citing works
Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India
Ganie, M. A., Vasudevan, V., Wani, I. A., Baba, M. S., Arif, T., & Rashid, A. (2019) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1937_17 · Cited by 232 · see citing works
Marsh, K. A., Steinbeck, K. S., Atkinson, F. S., Petocz, P., & Brand-Miller, J. C. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29261 · Cited by 228 · see citing works
Insulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209 · see citing works
Barber, T. M., Golding, S. J., Alvey, C., Wass, J. A. H., Karpe, F., Franks, S., & McCarthy, M. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2117 · Cited by 179 · see citing works
Barrea, L., Marzullo, P., Muscogiuri, G., Di Somma, C., Scacchi, M., Orio, F., Aimaretti, G., Colao, A., & Savastano, S. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422418000136 · Cited by 171 · see citing works
Self-citationMechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease
Muscogiuri, G., Mitri, J., Mathieu, C., Badenhoop, K., Tamer, G., Orio, F., Mezza, T., Vieth, R., Colao, A., & Pittas, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0158 · Cited by 157 · see citing works
Self-citationLean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Toosy, S., Sodi, R., & Pappachan, J. M. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0371-5 · Cited by 154 · see citing works
Nutritional management in women with polycystic ovary syndrome: A review study.
Faghfoori, Z., Fazelian, S., Shadnoush, M., & Goodarzi, R. (2017) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.030 · Cited by 153 · see citing works
Vitamin D and chronic diseases: the current state of the art
Muscogiuri, G., Altieri, B., Annweiler, C., Balercia, G., Pal, H. B., Boucher, B. J., Cannell, J. J., Foresta, C., Grübler, M. R., Kotsa, K., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1804-x · Cited by 151 · see citing works
Self-citationShedding new light on female fertility: the role of vitamin D
Muscogiuri, G., Altieri, B., de Angelis, C., Palomba, S., Pivonello, R., Colao, A., & Orio, F. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9407-2 · Cited by 142 · see citing works
Self-citationAn update of genetic basis of PCOS pathogenesis
Crespo, R. P., Bachega, T. A. S. S., Mendonça, B. B., & Gomes, L. G. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000049 · Cited by 138 · see citing works
Orio, F., Muscogiuri, G., Nese, C., Palomba, S., Savastano, S., Tafuri, D., Colarieti, G., La Sala, G., Colao, A., & Yildiz, B. O. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.08.026 · Cited by 126 · see citing works
Self-citationAssociation between Mediterranean diet and hand grip strength in older adult women
Barrea, L., Muscogiuri, G., Di Somma, C., Tramontano, G., De Luca, V., Illario, M., Colao, A., & Savastano, S. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.03.012 · Cited by 114 · see citing works
Self-citationAltieri, B., Grant, W. B., Della Casa, S., Orio, F., Pontecorvi, A., Colao, A., Sarno, G., & Muscogiuri, G. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1136922 · Cited by 113 · see citing works
Self-citationMechanisms IN endocrinology: metabolic syndrome through the female life cycle
Vryonidou, A., Paschou, S. A., Muscogiuri, G., Orio, F., & Goulis, D. G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0275 · Cited by 88 · see citing works
Self-citationPhysical activity before IVF and ICSI cycles in infertile obese women: an observational cohort study
Palomba, S., Falbo, A., Valli, B., Morini, D., Villani, M. T., Nicoli, A., & La Sala, G. B. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2014.03.006 · Cited by 87 · see citing works
Vitamin D in obesity and obesity-related diseases: an overview
Barrea, L., Frías-Toral, E., Pugliese, G., Garcia-Velasquez, E., Carignano, M. D. L. A., Savastano, S., Colao, A., & Muscogiuri, G. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03299-x · Cited by 87 · see citing works
Self-citationLow levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?
Muscogiuri, G., Policola, C., Prioletta, A., Sorice, G., Mezza, T., Lassandro, A., Della Casa, S., Pontecorvi, A., & Giaccari, A. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.010 · Cited by 86 · see citing works
Self-citationDefining the impact of dietary macronutrient balance on PCOS traits
Paris, V. R., Solon‐Biet, S. M., Senior, A. M., Edwards, M. C., Desai, R., Tedla, N. T., Cox, M. J., Ledger, W. J., Gilchrist, R. B., Simpson, S. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19003-5 · Cited by 83 · see citing works
Mediterranean Diet and Phase Angle in a Sample of Adult Population: Results of a Pilot Study
Barrea, L., Muscogiuri, G., Macchia, P. E., Somma, C. D., Falco, A., Savanelli, M. C., Colao, A., & Savastano, S. (2017) · Nutrients · doi:10.3390/nu9020151 · Cited by 80 · see citing works
Self-citationInsulin Sensitivity and β-Cell Function in Women With Polycystic Ovary Syndrome
Vrbíková, J., Bendlová, B., Hill, M., Vaňková, M., Vondra, K., & Stárka, L. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1217 · Cited by 80 · see citing works
Endocrine-metabolic dysfunction in polycystic ovary syndrome: An evolutionary perspective
Dumesic, D. A., Abbott, D. H., Sanchita, S., & Chazenbalk, G. D. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.02.013 · Cited by 76 · see citing works
Effects of physical exercise on the female reproductive system.
Orio, F., Muscogiuri, G., Ascione, A., Marciano, F., Volpe, A., Sala, G. B. L., Savastano, S., Colao, A., & Palomba, S. (2013) · PubMed · Cited by 76 · see citing works
Self-citationOrio, F., Muscogiuri, G., Giallauria, F., Savastano, S., Bottiglieri, P., Tafuri, D., Predotti, P., Colarieti, G., Colao, A., & Palomba, S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13112 · Cited by 75 · see citing works
Self-citationEffects of vitamin D supplementation in women with polycystic ovary syndrome: a review
Menichini, D., & Facchinetti, F. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1625881 · Cited by 73 · see citing works
Debates regarding lean patients with polycystic ovary syndrome: a narrative review
Dawood, A., & Goyal, M. (2017) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_77_17 · Cited by 72 · see citing works
Tosi, F., Di Sarra, D., Kaufman, J.-M., Bonin, C., Moretta, R., Bonora, E., Zanolin, E., & Moghetti, P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2786 · Cited by 70 · see citing works
Palomba, S., Falbo, A., Chiossi, G., Muscogiuri, G., Fornaciari, E., Orio, F., Tolino, A., Colao, A., La Sala, G. B., & Zullo, F. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.005 · Cited by 69 · see citing works
Self-citationKhashchenko, E., Vysokikh, M., Uvarova, E., Krechetova, L., Vtorushina, V., Ivanets, T., Volodina, M., Tarasova, N., Sukhanova, I., & Sukhikh, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051399 · Cited by 64 · see citing works
Nutritional guidelines for the management of insulin resistance
Muscogiuri, G., Barrea, L., Caprio, M., Ceriani, F., Chavez, A. O., El Ghoch, M., Frias-Toral, E., Mehta, R. J., Mendez, V., Paschou, S. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1908223 · Cited by 63 · see citing works
Self-citationDahan, M. H., & Reaven, G. M. (2019) · Endocrine · doi:10.1007/s12020-019-01899-9 · Cited by 62 · see citing works
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa108 · Cited by 60 · see citing works
Yildizhan, R., Ilhan, G. A., Yildizhan, B., Kolusari, A., Adali, E., & Bugdayci, G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.073 · Cited by 60 · see citing works
Moran, L., Brown, W. J., McNaughton, S. A., Joham, A. E., & Teede, H. J. (2016) · Human Reproduction · doi:10.1093/humrep/dew348 · Cited by 59 · see citing works
Paul, T., Satyaraddi, A., Cherian, K., Kapoor, N., Kunjummen, A., Kamath, M., & Thomas, N. (2019) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_2_19 · Cited by 57 · see citing works
Inositols in the Treatment of Insulin-Mediated Diseases
Muscogiuri, G., Palomba, S., Laganà, A. S., & Orio, F. (2016) · International Journal of Endocrinology · doi:10.1155/2016/3058393 · Cited by 56 · see citing works
Self-citationMuscogiuri, G., Palomba, S., Caggiano, M., Tafuri, D., Colao, A., & Orio, F. (2015) · Endocrine · doi:10.1007/s12020-015-0745-0 · Cited by 50 · see citing works
Self-citationMuscogiuri, G., Palomba, S., Laganà, A. S., & Orio, F. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160720160634 · Cited by 44 · see citing works
Self-citationPolycystic ovary syndrome and obesity: clinical aspects and nutritional management
Frías-Toral, E., Garcia-Velasquez, E., Carignano, M. D. L. A., Veintimilla, D. R., ALVARADO-AGUILERA, I., & Litardo, N. B. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03349-6 · Cited by 41 · see citing works
Self-citationAssociations between vitamin D levels and polycystic ovary syndrome phenotypes
Davis, E. M., Peck, J. D., Hansen, K. R., Neas, B. R., & Craig, L. B. (2019) · Minerva Endocrinologica · doi:10.23736/s0391-1977.18.02824-9 · Cited by 39 · see citing works
Pani, A., Gironi, I., Di Vieste, G., Mion, E., Bertuzzi, F., & Pintaudi, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/6276187 · Cited by 38 · see citing works
Penaforte, F. R. O., Japur, C. C., Diez-Garcia, R. W., & Chiarello, P. G. (2011) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2010.01130.x · Cited by 35 · see citing works
Karamali, M., Ashrafi, M., Razavi, M., Jamilian, M., Akbari, M., & Asemi, Z. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-104530 · Cited by 34 · see citing works
Leung, K. L., Sanchita, S., Pham, C. T., Davis, B. A., Okhovat, M., Ding, X., Dumesic, P., Grogan, T. R., Williams, K. J., Morselli, M., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00970-x · Cited by 33 · see citing works
Şahin, S., Eroğlu, M., Selcuk, S., Turkgeldi, L. S., Kozalı, Ş., Davutoğlu, S., & Muhçu, M. (2014) · PubMed · Cited by 26 · see citing works
Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome
Muscogiuri, G., Colao, A., & Orio, F. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.07.010 · Cited by 24 · see citing works
Self-citationLifestyle interventions and quality of life for women with polycystic ovary syndrome
Nunes, R. D. L., dos Santos, Í. K., Cobucci, R. N., Pichini, G. S., Soares, G. M., Maranhão, T. M. D. O., & Dantas, P. M. S. (2019) · Medicine · doi:10.1097/md.0000000000018323 · Cited by 24 · see citing works
Metabolic effects of polycystic ovary syndrome in adolescents
Han, Y., Kim, H. S., Lee, H.-J., Oh, J.-Y., & Sung, Y.-A. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.3.136 · Cited by 22 · see citing works
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin
Messer, C., Boston, R., Leroith, D., Geer, E., Miller, J. D., Messer, M., & Futterweit, W. (2012) · Endocrine Practice · doi:10.4158/ep11375.or · Cited by 16 · see citing works
Changes in Metabolic Profile in the Women with a History of PCOS—A Long-Term Follow-Up Study
Jacewicz‐Święcka, M., & Kowalska, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103367 · Cited by 14 · see citing works
Comparison of HbA1c levels in obese and non-obese polycystic ovarian patients.
Ünlüer, A. N., Fındık, R. B., Sevinc, N., & Karakaya, J. (2013) · PubMed · Cited by 10 · see citing works
Shi, Y., Zhao, D., Zhao, J., Li, Y., Liu, H., Sun, M., & Chen, Z. (2010) · PubMed · Cited by 6 · see citing works
Flagged first, then by citations
2 of the 80 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Langley‐Evans, S. C., Pearce, J., & Ellis, S. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12999 · Cited by 288 · see citing works
Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
parker, J., O'Brien, C., Hawrelak, J., & Gersh, F. (2021) · doi:10.20944/preprints202112.0088.v1 · Cited by 113 · see citing works
Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
Parker, J., O’Brien, C., Hawrelak, J., & Gersh, F. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031336 · Cited by 114 · see citing works
“Studies comparing obese and lean women with PCOS have a number of methodological problems including small sample size, overlap of PCOS characteristics with normal pubertal changes, non-standardized diagnostic criteria, and limited generalizability to the entire population due to a focus on a specific ethnic group (165…”
BackgroundKetogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)
Barrea, L., Verde, L., Camajani, E., Cernea, S., Frias-Toral, E., Lamabadusuriya, D., Ceriani, F., Savastano, S., Colao, A., & Muscogiuri, G. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00456-1 · Cited by 62 · see citing works
Self-citationDiagnosis and management of polycystic ovarian syndrome
Dason, E. S., Koshkina, O., Chan, C., & Sobel, M. L. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.231251 · Cited by 54 · see citing works
Barrea, L., Vetrani, C., Verde, L., Frías-Toral, E., Ceriani, F., Cernea, S., Docimo, A., Graziadio, C., Tripathy, D., Savastano, S., et al. (2023) · Antioxidants · doi:10.3390/antiox12040904 · Cited by 55 · see citing works
Self-citationSanchez-Garrido, M. A., Serrano-López, V., Ruíz-Pino, F., Vazquez, M. J., Rodríguez-Martín, A., Torres, E., Velasco, I., Rodríguez, A., Chicano‐Gálvez, E., Mora-Ortiz, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52898-y · Cited by 47 · see citing works
Liyanage, G. I. M., Inoüe, R., Fujitani, M., Ishijima, T., Shibutani, T., Abe, K., Kishida, T., & Okada, S. (2021) · Nutrients · doi:10.3390/nu13113759 · Cited by 42 · see citing works
Barrea, L., Verde, L., Annunziata, G., Camajani, E., Caprio, M., Šojat, A. S., Marina, L., Guarnotta, V., Colao, A., & Muscogiuri, G. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02169-2 · Cited by 32 · see citing works
Self-citationJuhász, A. E., Stubnya, M. P., Teutsch, B., Gede, N., Hegyi, P., Nyirády, P., Bánhidy, F., Ács, N., & Juhász, R. (2024) · Reproductive Health · doi:10.1186/s12978-024-01758-5 · Cited by 32 · see citing works
Chauvin, S. (2025) · Biomolecules · doi:10.3390/biom15070923 · Cited by 35 · see citing works
Glycemic Index and Glycemic Load Estimates in the Dietary Approach of Polycystic Ovary Syndrome
Manta, A., Paschou, S. Α., Isari, G., Mavroeidi, I., Kalantaridou, S., & Peppa, Μ. (2023) · Nutrients · doi:10.3390/nu15153483 · Cited by 33 · see citing works
Effect of Dietary Regimen on the Development of Polycystic Ovary Syndrome: A Narrative Review
Alomran, S., & Estrella, E. D. (2023) · Cureus · doi:10.7759/cureus.47569 · Cited by 23 · see citing works
Gomula, J., Warner, M., & Blandford, A. (2024) · BMC Women's Health · doi:10.1186/s12905-024-02993-5 · Cited by 22 · see citing works
Adelakun, S. A., Ukwenya, V. O., Peter, A. B., Siyanbade, J. A., & Akinwumiju, C. O. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100201 · Cited by 22 · see citing works
The Role of Individually Selected Diets in Obese Women with PCOS—A Review
Chudzicka-Strugała, I., Gołębiewska, I., Banaszewska, B., Brudecki, G. P., & Zwoździak, B. (2022) · Nutrients · doi:10.3390/nu14214555 · Cited by 22 · see citing works
Camajani, E., Feraco, A., Verde, L., Moriconi, E., Marchetti, M., Colao, A., Caprio, M., Muscogiuri, G., & Barrea, L. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00516-1 · Cited by 22 · see citing works
Self-citationEndocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review
Monney, M., Mavromati, M., Leboulleux, S., & Gariani, K. (2025) · Endocrine Connections · doi:10.1530/ec-24-0529 · Cited by 20 · see citing works
Diet patterns, gut microbiota and metabolic disorders: Perspectives and challenges
Dalamaga, Μ., & Tsigalou, C. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100310 · Cited by 19 · see citing works
Akpang, N., Kwiatkowski, J., Zaborowska, Ł., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094121 · Cited by 16 · see citing works
Evening chronotype is associated with hormonal and metabolic disorders in polycystic ovary syndrome
Barrea, L., Verde, L., Vetrani, C., Docimo, A., de Alteriis, G., Savastano, S., Colao, A., & Muscogiuri, G. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12844 · Cited by 18 · see citing works
Self-citationMizgier, M., Watrowski, R., Opydo-Szymaczek, J., Jodłowska-Siewert, E., Lombardi, G., Kędzia, W., & Jarząbek‐Bielecka, G. (2021) · Nutrients · doi:10.3390/nu14010073 · Cited by 14 · see citing works
Bila, J. S., Dotlić, J., Andjić, M., Ivanović, K., Micić, J., Tulić, L., Pupovac, M., Stojnić, J., Vuković, I., & Ivanovic, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165642 · Cited by 21 · see citing works
Unlocking the potential: very-low-energy ketogenic therapy in obesity-related disorders
Simancas‐Racines, D., Reytor-González, C., Zambrano, A. K., Annunziata, G., Am, C., Verde, L., Frías-Toral, E., Guerra, C. V., & Hidalgo, R. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2024.2442368 · Cited by 13 · see citing works
Self-citationMizgier, M., Więckowska, B., Formanowicz, D., Lombardi, G., Brożek, A., Nowicki, M., Durkalec‐Michalski, K., Kędzia, W., & Jarząbek‐Bielecka, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-54100-1 · Cited by 12 · see citing works
Khobragade, N. H., Sheth, D. B., Patel, C. A., Beladiya, J., Patel, S. P., & Dalal, M. (2024) · Steroids · doi:10.1016/j.steroids.2024.109455 · Cited by 11 · see citing works
Lean Polycystic Ovary Syndrome: A Narrative Review
Elnashar, A. M. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5106142 · Cited by 9 · see citing works
Nasrawi, A. J. M., Hussein, S. R. M., Sadiq, A. M., & Johar, S. A. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2023-0040 · Cited by 9 · see citing works
Liu, X., Zhang, C., Huang, J., Liu, H., Li, B., Zhang, F., & Xu, C. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117860 · Cited by 8 · see citing works
Dietary and lifestyle‐related factors behind delayed conception in females
Rizvi, M. K., Rabail, R., Munir, S., Rizvi, M. W., Abdi, G., & Aadil, R. M. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4274 · Cited by 7 · see citing works
Hu, B., He, X., Tan, J., Ma, Y., Wang, G., Liu, S., Li, M., Guo, Y., Sun, R., Sun, M., et al. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.957053 · Cited by 7 · see citing works
Suchta, K., Smolarczyk, R., Czajkowski, K., Rudnicka, E., & Kokoszka, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010546 · Cited by 7 · see citing works
Eshaghhosseiny, N., Ahmadi, M., Izadi, B., Vali, M., Akbari, M., Azari, I., & Akbari, H. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01441-3 · Cited by 9 · see citing works
Sherif, K., Coborn, J., Hoovler, A., & Gill, L. A. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2140511 · Cited by 6 · see citing works
The PCOS puzzle: putting the pieces together for optimal care
Dar, M. A., Maqbool, M., & Ara, I. (2023) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2023-0102 · Cited by 5 · see citing works
Chen, J., Zhang, L., Gan, J.-L., Teng, X., Huang, X., Lv, J., & Li, H. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01910-0 · Cited by 4 · see citing works
Hypertension and dyslipidemia in women with PCOS: a population-based multiregister study in Sweden
Persson, S., Türkmen, Ş., Hirschberg, A. L., Poromaa, I. S., & Elenis, E. (2026) · Human Reproduction · doi:10.1093/humrep/deag064 · Cited by 4 · see citing works
Clinical management of androgen excess and defect in women
Rosato, E., Sciarra, F., Minnetti, M., Degjoni, A., & Venneri, M. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2279537 · Cited by 4 · see citing works
Min, Q., Chen, Y., Geng, H., Gao, Q., Zhang, X., & Xu, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1282056 · Cited by 4 · see citing works
Diagnostic et prise en charge du syndrome des ovaires polykystiques
Dason, E. S., Koshkina, O., Chan, C., & Sobel, M. L. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.231251-f · Cited by 4 · see citing works
Gu, R., & Syed, N. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.417 · Cited by 3 · see citing works
Reytor-González, C., Verde, L., Annunziata, G., Román-Galeano, N. M., Horowitz, R., Galasso, M., Muscogiuri, G., Frias-Toral, E., Simancas‐Racines, D., & Barrea, L. (2026) · Current Nutrition Reports · doi:10.1007/s13668-026-00752-6 · Cited by 4 · see citing works
Self-citationNandagopal, P. B., Jayakrishnan, G., Kaithamattathil, A. V., & Manickam, V. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1821411 · Cited by 3 · see citing works
Diagnosis Experiences in Individuals With Lean Polycystic Ovary Syndrome
Masters, M. A., Dropping, K., Parry-Jones, A., & Sinley, R. C. (2024) · Nursing for Women s Health · doi:10.1016/j.nwh.2024.05.003 · Cited by 2 · see citing works
Pulluparambil, S. J., & Bhat, S. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106933 · Cited by 2 · see citing works
Diha, A. M., Uddin, M. S. S., Anha, K. M., Bekele, F. D., Naima, J., Al-Khulaifi, A. A. S., Nassar, A. A., & Huq, M. S. (2026) · Cureus · doi:10.7759/cureus.103615 · Cited by 3 · see citing works
Nutrition interventions in women with polycystic ovary syndrome: a systematic review
Akbaş, E., Samancı, M., & Öztürk, Y. E. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-04030-7 · Cited by 2 · see citing works
Clinical profiling of polycystic ovary syndrome patients in Kashmir population
Ashraf, A., Singh, R., & Shahnawaz, M. (2022) · Matrix Science Pharma · doi:10.4103/mtsp.mtsp_4_22 · Cited by 2 · see citing works
Baghbani, F., Alidousti, K., Parvizi, M. M., Ahmadi, A., Alamdarloo, S. M., Jaladat, A. M., & Atarzadeh, F. (2024) · PubMed Central · doi:10.30476/ijcbnm.2023.100249.2351 · Cited by 2 · see citing works
Assessment of Cdx2 polymorphism in Iranian women with polycystic ovary syndrome
Khansari, B., Nayeri, H., & Ostadsharif, M. (2023) · Middle East Fertility Society Journal · doi:10.1186/s43043-023-00155-5 · Cited by 2 · see citing works
Baghbani, F., Alidousti, K., Parvizi, M. M., Ahmadi, A., Alamdarloo, S. M., Jaladat, A. M., & Atarzadeh, F. (2023) · Research Square · doi:10.21203/rs.3.rs-2763633/v1 · Cited by 2 · see citing works
ALATAŞ, H., Arslan, N., KESKİN, L., & Ağralı, C. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s586793 · Cited by 1 · see citing works
INFLUÊNCIA DO EXCESSO PONDERAL SOBRE A FISIOPATOLOGIA DA SÍNDROME DOS OVÁRIOS POLICÍSTICOS
de Oliveira, N. S., Nascimento, J. M. D. S., & Melo, N. C. D. O. (2022) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v3i1.1049 · Cited by 1 · see citing works
A Comparison of Eating Attitudes, Diet Quality, and Nutrition Knowledge in Polycystic Ovary Syndrome
ULUDAĞ, B. D., & CEBİRBAY, M. A. (2022) · Journal of Contemporary Medicine · doi:10.16899/jcm.1138300 · Cited by 1 · see citing works
Complex metabolic–endocrine syndromes: associations with cardiovascular disease
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00010-3 · Cited by 1 · see citing works
Shalchian, Z., Taheri, S., Hafezi, M., Madani, T., Nasiri, N., & Eftekhari‐Yazdi, P. (2023) · PubMed Central · doi:10.22074/ijfs.2023.2006784.1491 · Cited by 1 · see citing works
Elkhyat, A., Elsokary, A., & Elshwaikh, S. L. (2024) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.9.1.70 · Cited by 1 · see citing works
Masters, M. A., & Grevstad, N. (2025) · Open Health · doi:10.1515/ohe-2023-0055 · Cited by 1 · see citing works
Spyroglou, A., Konstantakou, P., Minnetti, M., Altieri, B., Nowak, E., Papalexis, P., Angelousi, A. G., Vasiliadi, D., Kimpel, O., Macut, D., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04369-7 · Cited by 1 · see citing works
Association of Primary Subfertility in Polycystic Ovarian Syndrome with BMI and Waist Circumference
Waheed, F., Muhabat, Q., Bhatti, U., Effendi, S., Koshila, & Mumtaz, F. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2115113531
Fasitasari, M., Aryani, R., & Samsudin, S. (2024) · Jurnal ABDIMAS-KU Jurnal Pengabdian Masyarakat Kedokteran · doi:10.30659/abdimasku.1.1.13-26
Dietary Habits and their Impact on Physical Symptoms Severity in Young Females Diagnosed with PCOS
Saeed, S. (2024) · Lahore Garrison University Journal of Life Sciences · doi:10.54692/lgujls.2024.0801326 · Cited by 2 · see citing works
Suchta, K., Smolarczyk, R., Hajbos, M., & Kokoszka, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237100
Empowering Young Women with Polycystic Ovary Syndrome through Food and Nutrition Literacy
Mathema, S., Aryal, B., & Subedi, S. (2024) · Journal of Health Promotion · doi:10.3126/jhp.v12i1.72710
Turemka, M., Mandziuk, A., Cygnarowicz, A., Wojtas, A. K., Zabojska, K., Korotko, U., Witowska, K., Biskupski, M., Hosseinnejad, N., & Sacher, K. (2024) · Quality in Sport · doi:10.12775/qs.2024.36.56601 · Cited by 1 · see citing works
Othman, N., Maulood, K. A., & Darogha, S. N. (2024) · Kirkuk journal of science · doi:10.32894/kujss.2024.152183.1166
Varghese, V., Ayyappan, J. P., & Vankudre, G. S. (2025) · Springer eBooks · doi:10.1007/978-981-96-2120-0_2
Mustafa, M., Babur, M., Shah, S., Shafiq, A., & Aslam, R. (2025) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v6i6.3179
Polycystic Ovarian Syndrome: A Clinical Review
Nettles, A. (2025) · Lynchburg Journal of Medical Science · doi:10.63932/3067-7106.1020
Flavonoids and Their Potential in Alleviating PCOS Symptoms: A Thorough Review
Upadhyay, S., Mazumder, A., & Das, S. (2025) · Journal of Natural Remedies · doi:10.18311/jnr/2025/49182
Ji, X.-L., Cui, Q. C., Lei, L.-Z., Zhang, J., & Li, Y. (2025) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000148
Gomula, J., Warner, M., & BLANDFORD, A. E. (2024) · Figshare · doi:10.6084/m9.figshare.26689010
Juhász, A. E., Stubnya, M. P., Teutsch, B., Gede, N., Hegyi, P., Nyírády, P., Bánhidy, F., Ács, N., & Juhász, R. (2024) · Figshare · doi:10.6084/m9.figshare.25271775
Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
Aksu, E., & Gül, A. (2025) · Journal of Contemporary Medicine · doi:10.16899/jcm.1794476
MicroRNA Crossroads in PCOS and Endometriosis
Sambath, G., Kalai, J., Usha Rani, G., Osborne, J. W., Sumitha, R., & Parvathi, V. D. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-02037-9
Wei, S., Wang, Y., Liu, N., & Zhao, R. (2025) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-025-01801-9
Dietary prevention and diet therapy for selected reproductive healthdisorders in women
Szymkowiak, A., & Pisarski, R. K. (2025) · Zeszyty Naukowe Collegium Witelona · doi:10.5604/01.3001.0055.5686
Natarajan, M., Shweatha, H. E., & Nataraj, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1766838
Fayyaz, K., Iqbal, S., Altaf, I., Khan, Z., & Shahbaz, H. M. (2026) · Nutrition · doi:10.1016/j.nut.2026.113232
Menek, M. Y., Sen, M., & Pehlivan, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1758959
Polycystic Ovarian Syndrome: A Breakthrough Etiology, Symptoms and Therapy
Gomaa, H. F. (2026) · JOURNAL of QASSIM UNIVERSITY FOR SCIENCE · doi:10.25259/jqus_14_2026
Stolarska, K., Gaj-Hunter, A., Rędziniak, P., Ruzik, A., Rajs, M., Przebieradło, P., Żak, S., Kowalska, M., Żurek, K., & Terpiłowska, S. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5971
Metabolic syndrome in lean versus obese polycystic ovarian syndrome (PCOS) phenotype
Goyal, N., Sharma, S., Bhatia, R., Gupta, S., & Pai, R. (2026) · Scripta Medica · doi:10.5937/scriptamed57-60700
Correlation between age, BMI and sexual hormones levels among PCOS women
Imran, R. E., & Faris, R. A. (2026) · AIP conference proceedings · doi:10.1063/5.0330242
Deciphering the Insulin Link: Exploring Metabolic Interplay in Polycystic Ovary Syndrome
Maqbool, M., Qadrie, Z., & Ashraf, H. (2026) · Tropical Journal of Pharmaceutical and Life Sciences · doi:10.61280/tjpls.v13i4.285
Pugalendhi, M. A., & Sankarganesh, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1906736
Halder, D., Varshini, P., V, Mitra, T., Kumar, A. H. S. A., Agrawal, P., Das, M., Kumar, A. H. S. A., Kumari, R. S., Sundari, S. N. M., & Janardhanan, R. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1868855
- Authors
- Barrea, L., Frias-Toral, E., Verde, L., Ceriani, F., Cucalón, G., Garcia-Velasquez, E., Moretti, D., Savastano, S., Colao, A., & Muscogiuri, G.
- Affiliations
- Pegaso University (IT)
- Federico II University Hospital (IT)
- Universidad de la República de Uruguay (UY)
- Escuela Superior Politecnica del Litoral (EC)
- Kennedy Clinic Hospital (EC)
- Corresponding author
- Muscogiuri, Giovanna
- ORCID
- Venue
- Metabolism Open
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 12
- Pages
- 100123
- ISSN
- 2589-9368 (ISSN-L)
- PMC
- PMC8479825
- OpenAlex
- W3199299133
- Cited by
- 86
- References
- 80
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 23 · 2023: 15 · 2022: 11 · 2021: 3
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Metabolism Open (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, body composition, dietary intervention, dietary habits, insulin resistance, hyperandrogenism, cardiometabolic dysfunction, personalized treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review